Yes, Valtrex (valacyclovir) can be taken once daily as suppressive therapy to prevent herpes outbreaks
Valacyclovir 500 mg or 1 gram once daily is FDA-approved and guideline-recommended for daily suppressive therapy of recurrent genital herpes 1. This regimen reduces outbreak frequency by ≥75% and is safe for long-term use 2.
Dosing Algorithm for Suppressive Therapy
For immunocompetent patients with recurrent genital herpes:
- Standard dose: 1 gram once daily 1
- Alternative for ≤9 recurrences/year: 500 mg once daily 1
- For ≥10 recurrences/year: Use 1 gram once daily (the 500 mg dose is less effective in very frequent recurrences) 2
For HIV-infected patients (CD4+ ≥100 cells/mm³):
For transmission reduction in discordant couples:
Evidence Supporting Once-Daily Dosing
The FDA label explicitly lists both 500 mg and 1 gram once-daily regimens as approved suppressive therapy options 1. CDC guidelines from 1998 confirm these same dosing options 2.
Research demonstrates that once-daily valacyclovir is highly effective: a large dose-ranging study of 1,479 patients showed all valacyclovir dosages significantly outperformed placebo (P<0.0001), with a clear dose-response relationship 5. Another study found 500 mg once daily prevented or delayed 85% of recurrences that would have occurred with placebo 6.
Clinical Benefits Beyond Outbreak Prevention
Suppressive therapy provides multiple benefits:
- Reduces recurrence frequency by ≥75% 2
- Decreases asymptomatic viral shedding (from 10.8% to 2.9% of days) 4
- Reduces transmission risk by 48-75% in heterosexual discordant couples 4
- Improves herpes-related quality of life scores 7
- Does not lead to clinically significant acyclovir resistance in immunocompetent patients 2
Important Caveats and Considerations
Duration of therapy: While the 1998 CDC guidelines noted "insufficient experience" recommending valacyclovir beyond 1 year at that time 2, subsequent research has demonstrated safety with prolonged use up to 24 months 8. After 1 year of continuous therapy, discuss discontinuation with patients to reassess recurrence patterns, as outbreak frequency naturally decreases over time in many patients 2.
Dosing pitfall: The 500 mg once-daily dose appears less effective in patients with very frequent recurrences (≥10 episodes/year) 2. For these patients, use 1 gram once daily instead.
Does not eliminate transmission risk: Suppressive therapy reduces but does not eliminate asymptomatic viral shedding 2. Patients should still practice safer sex, use condoms with new or uninfected partners, and avoid sexual activity during prodromal symptoms or active lesions 2.
Not studied for all populations: Efficacy beyond 8 months for transmission reduction has not been established 1. The transmission reduction data applies specifically to heterosexual discordant couples and has not been established for individuals with multiple partners or non-heterosexual couples 1.
Practical Implementation
Valacyclovir can be taken without regard to meals 1. The once-daily dosing provides significantly better convenience and adherence compared to twice-daily acyclovir regimens (400 mg twice daily), while maintaining comparable clinical outcomes 2, 5.